Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details Narrative)

v3.10.0.1
NON CONTROLLING INTEREST (Details Narrative) - USD ($)
Dec. 31, 2017
Jul. 28, 2016
Brady Granier, Lourdes Felix and Kent Emry [Member]    
Sub issued ownership percentage   24.20%
BioCorRx Pharmaceuticals, Inc [Member]    
Company ownership percentage   75.80%
Licensing rights, carrying value $ 250,000